To seek capital appreciation through investment in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Find out MoreTIDM | BIOG |
---|---|
Ticker Code | BIOG.L |
ISIN | GB0000385517 |
Currency | GBX |
Issue Country | GB |
Sector | NMX302040 |
Year End | 30-Mar-23 |
Shares in Issue | 33.49m |
---|---|
Market Cap. | £311.77m |
Market Size | 1,000 |
PE Ratio | -9.082927 |
Earnings | -102.50 |
Dividend | 0.00 |
Yield | 0.00% |
# of Trades | 53 |
---|---|
Vol Sold | 18,612 |
Vol Bought | 31,425 |
52 Week High | 1,034.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 715.00 |
52 Week Low Date | 26-Oct-2023 |
Standard | GAAP | GAAP | GAAP | GAAP | GAAP |
---|---|---|---|---|---|
Millions | Millions | Millions | Millions | Millions | |
Income Statement | 30 Mar '23 | 30 Mar '22 | 31 Mar '21 | 30 Mar '21 | 31 Mar '20 |
Turnover | 0.31 | 1.08 | 0.99 | 0.99 | 1.31 |
Operating Profit / Loss | (0.56) | 0.17 | 0.07 | 0.07 | 0.66 |
Net Interest | (0.04) | (0.01) | (0.01) | (0.01) | n/a |
Pre Tax Profit | (0.60) | 0.16 | 0.06 | 0.06 | 0.66 |
Post Tax Profit | (0.65) | 0.01 | (0.07) | (0.07) | 0.47 |
Continuing EPS | |||||
Earnings per Share (Basic) | (1.60p) | n/a | n/a | (0.20p) | n/a |
Earnings per Share (Diluted) | (1.60p) | n/a | n/a | (0.20p) | n/a |
Earnings per Share (Adjusted) | (1.60p) | n/a | n/a | (0.20p) | n/a |
Continuing and Discontinued EPS | |||||
Earnings per Share (Basic) | (1.60p) | n/a | (0.20p) | (0.20p) | 1.00p |
Earnings per Share (Diluted) | (1.60p) | n/a | (0.20p) | (0.20p) | 1.00p |
Earnings per Share (Adjusted) | (1.60p) | n/a | (0.20p) | (0.20p) | 1.00p |
Dividend per Share | n/a | n/a | n/a | n/a | n/a |
Millions | Millions | Millions | Millions | Millions | |
Balance Sheet | 30 Mar '23 | 30 Mar '22 | 31 Mar '21 | 30 Mar '21 | 31 Mar '20 |
Non-Current Assets | |||||
Intangible Assets | n/a | n/a | n/a | n/a | n/a |
Tangible Assets | n/a | n/a | n/a | n/a | n/a |
Fixed Investments | 357.23 | 427.40 | 643.27 | 643.27 | 398.66 |
Total Fixed Assets | 357.23 | 427.40 | 643.27 | 643.27 | 398.66 |
Current Assets | |||||
Stocks | n/a | n/a | n/a | n/a | n/a |
Debtors | 0.51 | 0.05 | 4.76 | 4.76 | 2.53 |
Cash at Bank and in Hand | 2.77 | n/a | 1.50 | 1.50 | n/a |
Total Assets | 360.51 | 427.45 | 649.53 | 649.53 | 401.19 |
Current Liabilities | |||||
Creditors Within 1Yr | 30.22 | 33.24 | 48.06 | 48.06 | 35.62 |
Net Current Assets | (26.94) | (33.19) | 601.47 | 601.47 | 365.57 |
Non-Current Liabilities | |||||
Creditors After 1Yr | n/a | n/a | n/a | n/a | n/a |
Net Assets | 330.29 | 394.21 | 601.47 | 601.47 | 365.57 |
Capital and Reserves | |||||
Called Up Share Capital | 9.68 | 10.29 | 10.40 | 10.40 | 9.80 |
Share Premium Account | 79.95 | 79.95 | 77.89 | 77.89 | 43.02 |
Other Reserves | 241.71 | 304.37 | 513.59 | 513.59 | 313.10 |
Shareholders Funds | 330.29 | 394.21 | 601.47 | 601.47 | 365.57 |
Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
30 Mar '23 | 30 Mar '22 | 31 Mar '21 | 30 Mar '21 | 31 Mar '20 | |
Operating Margin | (180.00%) | 15.59% | 7.20% | 7.20% | 50.42% |
Return on Capital Employed | n/a | n/a | n/a | n/a | n/a |
Dividend Cover | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
PE Ratio | n/a | n/a | n/a | n/a | 814.00 |
PEG | n/a | n/a | n/a | n/a | n/a |
Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
Net Asset Value per Share | 876.58p | 1,046.21p | 1,442.89p | 1,596.27p | 876.99p |